Comparative Metabolism in Vitro of a Novel Carcinogenic Polycyclic Aromatic Hydrocarbon, l929394-Tetrahydro-7912-dimethylbenz[a]anthracene9 and Its Two Regioisomeric B-Ring Fluoro Analogues

Cancer Research

Volumn 52, Issue 11, 1992, Pages 3035-3042

  Rinderle, Stephen J ^a   Black, Shaun D ^a   Sharma, Pradeep K ^a   Witiak, Donald T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTHRACENE DERIVATIVE; FLUORINE; OXYGEN; POLYCYCLIC AROMATIC HYDROCARBON; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CARCINOGENIC ACTIVITY; CHEMICAL STRUCTURE; DNA BINDING; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LIVER MICROSOME METABOLISM; MALE; MASS SPECTROMETRY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; BIOTRANSFORMATION; CARBON RADIOISOTOPES; CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPARATIVE STUDY; ISOMERISM; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; PHENOBARBITAL; RATS; RATS, INBRED STRAINS; SPECTRUM ANALYSIS, MASS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026629185     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sims, P., Grover, P. L., Swaisland, A., Pal, K., and Hewer, A. Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature (Lond.), 252:326-328, 1974.
2. Conney, A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res., 42:4875-4917, 1982.
3. Levin, W., Thakker, D. R., Wood, A. W., Chang, R. L., Lehr, R. E., Jenna, D. M., and Conney, A. H. Evidence that benzo(a]anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. Cancer Res., 38: 1705-1710, 1978.
4. Moschel, R. C., Baird, W. M., and Dipple, A. Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA binding. Biochem. Biophys. Res. Commun., 76:1092-1098, 1977.
5. Weinstein, I. B., Jeffrey, A. M., Jennette, K. W., Blobstein, S. H., Harvey, R. G., Harris, C., Autrup, H., Kasai, H., and Nakanishi, K. Benzo[a]pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (Washington DC), 193:592-595, 1976.
6. Dipple, A., Moschel, R. C., and Bigger, C. A. H. Polynuclear aromatic carcinogens. In: C. E. Searle (ed.), Chemical Carcinogens, ACS Monograph 182, Vol. 1, pp. 41-163. Washington, DC: American Chemical Society, 1984.
7. Newman, M. S., Tierney, B., and Veeraraghavan, S. In: The Chemistry and Biology of Benz[a]anthracenes, Cambridge Monographs on Cancer Research. Cambridge: Cambridge University Press, 1988.
8. Hall, M., and Grover, P. L. Polycyclic aromatic hydrocarbons: metabolism, activation, and tumour initiation. In: C. S. Cooper and P. L. Grover (eds.), Handbook of Experimental Pharmacology: Chemical Carcinogenesis and Mutagenesis, Vol. 94/1, pp. 327-372. New York: Springer-Verlag, 1990.
9. Harvey, R. G., and Dunne, F. B. Multiple regions of metabolic activation of carcinogenic hydrocarbons. Nature (Lond.), 273:566-568,1978.
10. Lijinsky, W., Manning, W. B., and Andrews, A. W. Skin carcinogenesis tests in mice of derivatives of 7,12-dimethylbenz[a]anthracene substituted in the “A ring. Carcinogenesis (Lond.), 4: 1221-1224,1983.
11. Tejwani, R., Witiak, D. T., Inbasekaran, M. N., Cazer, F. D., and Milo, G. E. Characteristics of benzo(a]pyrene and A-ring reduced 7,12-dimethyl-benz[a]anthracene induced neoplastic transformation of human cells in vitro. Cancer Lett., 13: 119-127, 1981.
12. Kumari, H. L., Milo, G. E., and Witiak, D. T. Cytotoxicity, anchorage-independent growth, and DNA adduct formation in human neonatal fibroblasts by l,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene (TH-DMBA), its six aryl fluoro regiomers, and an exo methylene tautomer. Teratog. Carcinog. Mutagen., 10: 247-262, 1990.
13. DiGiovanni, J., Diamond, L., Singer, J. M., Daniel, F. B., Witiak, D. T., and Slaga, T. J. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz(aj anthracene and l,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. Carcinogenesis (Lond.), 3:651-655,1982.
14. Inbasekaran, M. N., Witiak, D. T., Barone, K., and Loper, J. C. Synthesis and mutagenicity of A-ring reduced analogues of 7,12-dimethylbenz[a]an-thracene. J. Med. Chem., 23:278-281, 1980.
15. Sheik, Y. M., Hart, R. W., and Witiak, D. T. A study of steric and electronic factors governing the position of biofunctionalization of the benz(a]anthra-cene nucleus: metabolism in vitro of fluoro-and methyl-substituted analogs. Bioorg. Chem., 10:429-442,1981.
16. Chiu, P-L., Fu, P. P., and Yang, S. K. Stereoselectivity of rat liver microsomal enzymes in the metabolism of 7-fluorobenz(a]anthracene and mutagenicity of metabolites. Cancer Res., 44: 562-570,1984.
17. Buhler, D. R., Unlu, F., Thakker, D. R., Slaga, T. J., Newman, M. S., Levin, W., Conney, A. H., and Jerina, D. M. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrene. Cancer Res., 42:4779-4783,1982.
18. Buhler, D. R., Unlu, F., Thakker, D. R., Slaga, T. J., Conney, A. H., Wood, A. W., Chang, R. L., Levin, W., and Jerina, D. M. Effect of a 6-fluoro substituent on the metabolism and biological activity of benzo(a)pyrene. Cancer Res., 43: 1541-1549,1983.
19. DiGiovanni, J., Sawyer, T. W., and Fisher, E. P. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and its 9-and 10-monofluoro derivatives in mice. Cancer Res., 46:4336-4341,1986.
20. Huberman, E., and Slaga, T. J. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz[a]anthracene. Cancer Res., 39: 411-414,1979.
21. Black, S. D., and Coon, M. J. P-450 cytochromes: structure and function. Adv. Enzymol. Relat. Areas Mol. Biol., 60:35-87, 1987.
22. White, R. E., and Coon, M. J. Oxygen activation by cytochrome P-450. Annu. Rev. Biochem., 49:315-336, 1980.
23. Witiak, D. T., Abood, N. A., Goswami, S., and Milo, G. E. The 5-, 6-, and 10-fluoro-1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracenes: comparative acid catalyzed isomerization to exo methylene tautomers: a 6-fluoro peri effect. J. Org. Chem., 51:4499-4507, 1986.
24. Omura, T., and Sato, R. The carbon monoxide-binding pigment of liver microsomes: evidence for its hemoprotein nature. J. Biol. Chem., 239:23702378, 1964.
25. Yang, S. K., Chou, M. W., and Roller, P. P. Potential proximate carcinogens of 7,12-dimethylbenz[a]anthracene: characterization of two metabolically formed fran5-3,4-dihydrodiols. J. Am. Chem. Soc., 101:237-239, 1979.
26. Rogan, E. G., Cavalieri, E. L., Walker, B. A., Balasubramanian, R., Wislocki, P. G., Roth, R. W., and Saugier, R. K. Mutagenicity of benzlic acetates, sulfates, and bromides of polycyclic aromatic hydrocarbons. Chem.-Biol. Interact., 58:253-275,1986.
27. Chou, M. W., and Yang, S. K. Identification of four fro/w-3,4-dihydrodiol metabolites of 7,12-dimethylbenz[a]anthracene and their in vitro DNA-binding activities upon further metabolism. Proc. Natl. Acad. Sci. USA, 75: 5466-5470,1989.
28. Boyland, E., and Sims, P. Metabolism of polycyclic compounds: the metabolism of 7,12-dimethylbenz[a]anthracene by rat-liver homogenates. Biochem. J., 95: 780-787,1965.
29. Jellinck, P. H., and Goudy, B. Protective action of polycyclic hydrocarbons against induction of adrenal necrosis by dimethylbenzanthracene. Science (Washington DC), 152:1375-1376, 1966.
30. Yang, S. K., and Dower, W. V. Metabolic pathways 7,12-dimethylbenz[a] anthracene in hepatic microsomes. Proc. Natl. Acad. Sci. USA, 72: 26012605, 1975.
31. Daniel, F. B., Cazer, F. D., D'Ambrosio, S. M., Hart, R. W., Kim, W. H., and Witiak, D. T. Comparative metabolism and DNA binding of 7,12-dimethylbenz(a]anthracene and its weakly carcinogenic 5-fluoro analog. Cancer Lett., 6:263-272, 1979.
32. Morse, M. A., Baird, W. M., and Carlson, G. P. Distribution, covalent binding, and DNA adduct formation of 7,12-dimethylbenz[a]anthracene in SENCAR and BALB/c mice following topical and oral administration. Cancer Res., 47:4571-4575, 1987.
33. Slaga, T. J., Gleason, G. L., DiGiovanni, J., Sukumavan, K. B., and Harvey, R. G. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(o)anthracene in mouse skin. Cancer Res., 39:1934-1936,1979.
34. Wislocki, P. G., Gadek, K. M., Chou, M. W., Yang, S. K., and Lu, A. Y. H. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz[fl]anthracene and its hydroxymethyl derivatives. Cancer Res., 40:3661-3664, 1980.
35. Copper, C. S., Ribeiro, O., Hewer, A., Walsh, C., Grover, P. L., and Sims, P. Additional evidence for the involvement of the 3,4-diol-1,2-oxides in the metabolic activation of 7,12-dimethylbenz[a]anthracene in mouse skin. Chem.-Biol. Interact., 29:357-367,1980.
36. Bigger, C. A. H., Sawicki, J. T., Blake, D. M., Raymond, L. G., and Dipple, A. Products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin. Cancer Res., 43:5647-5651, 1983.
37. Dipple, A., Pigott, M., Moschel, R. C., and Costantino, N. Evidence that binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res., 43:4132-4135,1983.
38. Ivanovic, V., Geacintov, N. E., Jefferey, A. M., Fu, P. P., Harvey, R. G., and Weinstein, L. B. Cell and microsome mediated binding of 7,12-dimethyl-benz[a]anthracene to DNA studied by fluorescence spectroscopy. Cancer Lett., 4:131-140,1978.
39. Watabe, T., Ishizuka, T., Isobe, M., and Ozawa, N. A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science (Washington DC), 215:403-405, 1982.
40. Watabe, T., and Ishizuka, T. The role of L-region methyl substituents in the metabolic activation of the potent carcinogen, 7,12-dimethylbenz[a]anthra-cene (DMBA). J. Pharm. Dyn., 5: S-57, 1982.
41. Watabe, T., Ishizuka, T., Hakamata, Y., Aizawa, T., and Isobe, M. Covalent binding of the proximate carcinogen, 7-hydroxymethyl-12-methylbenz(a] anthracene (7-HMBA) to rat liver cytosolic protein via 7-HMBA sulphate. Biochem. Pharmacol., 32:2120-2122,1983.
42. Surh, Y-J., Lai, C-C., Miller, J. A., and Miller, E. C. Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12-methyl-benz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice. Biochem. Biophys. Res. Commun., 144: 576-582, 1987.
43. Surh, Y-J., Lai, C-C., Liem, A., Miller, E. C., and Miller, J. A. Hepatic metabolic activation and nucleic acid adducts of 6-hydroxymethylbenzo[a] pyrene (HMBP) and 7-hydroxymethyl-12-methylbenz[a]anthracene via electrophilic sulfuric acid esters in infant rats and mice. Proc. Am. Assoc. Cancer Res., 30: 121, 1989.
44. Watabe, T., Hiratsuka, A., Ogura, K., and Endoh, K. A reactive hydroxymethyl sulfate ester formed regioselectively from the carcinogen, 7,12-di-methylbenz[a]anthracene, by rat liver sulfotransferase. Biochem. Biophys. Res. Commun., 131:694-699,1985.
45. Surh, Y-J., Liem, A., Miller, E. C., and Miller, J. A. Metabolic activation of the carcinogen 6-hydroxymethylbenzo(a)pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Carcinogenesis (Lond.), 10:1519-1528,1989.
46. Surh, Y-J., Blomquist, J. C., Liem, A., and Miller, J. A. Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethyl pyrene to electrophilic, mutagenic, and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Carcinogenesis (Lond.), 11:1451-1460,1990.
47. Okuda, H., Hiratsuka, A., Nojima, H., and Watabe, T. A hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 5-hydroxymethyl-chrysene. Biochem. Pharmacol., 35:538-541,1986.
48. Surh, Y-J., Liem, A., Miller, E. C., and Miller, J. A. The strong hepatocar-cinogenicity of the electrophilic and mutagenic metabolite 6-sulfooxymethyl-benzo[a]pyrene and its formation of benzylic DNA adducts in the livers of infant male B6C3Fi mice. Biochem. Biophys. Res. Commun., 172: 85-91, 1990.
49. Shear, M. J. Studies in carcinogenesis, methyl derivatives of l:2-benzanthra-cene. Am. J. Cancer, 33:499-537,1938.
50. Witiak, D. T., and Nair, R. V. Metabolism of polyaromatic hydrocarbons by human fibroblasts. In: G. E. Milo and B. C. Casto (eds.), Transformation of Human Diploid Fibroblast: Molecular and Genetic Mechanisms, pp. 175-193. Boca Raton, FL: CRC Press, 1990.